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Abstract
VACTERL/VATER association is typically defined by the presence of at least three of the following congenital
malformations: vertebral defects, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies, and limb
abnormalities. In addition to these core component features, patients may also have other congenital anomalies.
Although diagnostic criteria vary, the incidence is estimated at approximately 1 in 10,000 to 1 in 40,000 live-born
infants. The condition is ascertained clinically by the presence of the above-mentioned malformations; importantly,
there should be no clinical or laboratory-based evidence for the presence of one of the many similar conditions, as
the differential diagnosis is relatively large. This differential diagnosis includes (but is not limited to) Baller-Gerold
syndrome, CHARGE syndrome, Currarino syndrome, deletion 22q11.2 syndrome, Fanconi anemia, Feingold
syndrome, Fryns syndrome, MURCS association, oculo-auriculo-vertebral syndrome, Opitz G/BBB syndrome, Pallister-
Hall syndrome, Townes-Brocks syndrome, and VACTERL with hydrocephalus. Though there are hints regarding
causation, the aetiology has been identified only in a small fraction of patients to date, likely due to factors such as
a high degree of clinical and causal heterogeneity, the largely sporadic nature of the disorder, and the presence of
many similar conditions. New genetic research methods offer promise that the causes of VACTERL association will
be better defined in the relatively near future. Antenatal diagnosis can be challenging, as certain component
features can be difficult to ascertain prior to birth. The management of patients with VACTERL/VATER association
typically centers around surgical correction of the specific congenital anomalies (typically anal atresia, certain types
of cardiac malformations, and/or tracheo-esophageal fistula) in the immediate postnatal period, followed by long-
term medical management of sequelae of the congenital malformations. If optimal surgical correction is
achievable, the prognosis can be relatively positive, though some patients will continue to be affected by their
congenital malformations throughout life. Importantly, patients with VACTERL association do not tend to have
neurocognitive impairment.
Disease name and synonyms
VACTERL association (ORPHA887)
VATER association (ORPHA887)
Definition and diagnostic criteria
VATER association was first named in the early 1970’s.
As initially described, the condition included the statisti-
cally non-random co-occurrence of a group of congeni-
tal malformations: Vertebral defects, Anal atresia,
Tracheo-Esophageal fistula (TEF) with esophageal atre-
sia, and Radial and Renal dysplasia [1,2]. Because these
malformations were observed to occur together more
often than would be expected by chance, the condition
was termed an association. However, there was not (and
still remains no) evidence for a single, unifying cause
that would result in the condition being termed a syn-
drome. One explanation for the clustering of features
involves the idea of the “developmental field defect”,i n
which malformations that occur in blastogenesis tend to
result in polytopic anomalies, or birth defects affecting
multiple organ systems. Some authors have suggested
that VACTERL association would be more accurately
described as a “primary polytopic developmental field
defect” (as this reflects the causative developmental per-
turbation) rather than an association (as this simply
describes the presence of statistical clustering) [3,4].
Shortly after the initial description, it was proposed
that the diagnostic criteria should also include Vascular
anomalies (as part of the “V” in VACTERL), including
single umbilical artery, or SUA, as part of the definition.
Cardiac malformations ("C”) and additional Limb ("L”)
anomalies other than strict radial anomalies were added
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any medium, provided the original work is properly cited.as well [5,6]. Later, statistical analyses of cohorts of
affected patients suggested that there was overall less
evidence for the inclusion of certain features, such as
cardiac or renal anomalies [7-9]. There is still no firm
consensus regarding strict diagnostic criteria, though
most clinicians and researchers require the presence of
at least three component features for diagnosis
(although it may be a semantic point, some would argue
that the condition is observed rather than truly diag-
nosed, and while this may be an important distinction,
the term “diagnosis” and its derivatives will be used
throughout this article). Others have stressed emphasis
on certain “core” features such as TEF or anorectal mal-
formations (ARM) [10]. Equally importantly, as the dif-
ferential diagnosis is quite broad, careful clinical and
laboratory-based analysis should not yield evidence of
an alternative diagnosis (see the Differential diagnosis
section below). For further details regarding each com-
ponent feature, see the Clinical description section
below.
Epidemiology
As various studies have used differing diagnostic criteria
and ascertainment methods, the incidence is difficult to
pinpoint. Studies have estimated the frequency to be
between less than 1/10,000 to 1/40,000 infants (approxi-
mately <1-9/100,000 infants) [8,11,12]. However, care
must be taken when interpreting these values. First, dif-
ferent studies have used differing diagnostic criteria.
Second, some larger studies extracted data from large
malformation registries. These studies, while extremely
valuable, may not be designed to be able to strictly rule-
out patients with similar but distinct conditions. Along
these lines, many older studies were not able to test for
similar conditions for which genetic testing is now avail-
able, such as Fanconi anemia or chromosomal anomalies
detectable on karyotype or microarray. Both of these
types of studies would likely overestimate the incidence
of VACTERL association, which is likely the reason that
some estimates make the condition appear much more
common than it likely is in reality. On the other hand,
studies based on patients who survive to present to
clinics or participate in research studies underestimate
the incidence, as only less severely-affected patients are
included. Finally, it must be noted that due to modern
surgical techniques and specialized hospitalization units
(such as neonatal intensive care units), infants born with
VACTERL association today have a much better prog-
nosis than several decades ago, which would skew epide-
miological data in many types of studies, especially if
only infants that survive the immediate postnatal period
are included.
There is overall no strong evidence for an increased
incidence of VACTERL association in certain areas of
the world or in specific ethnic populations. Relatively
large cohorts of patients have been described from all
parts of the world in which such studies have been con-
ducted [7-17]. Some but not all studies have suggested
that the condition is more common in males. As the
causes of VACTERL association appear to be heteroge-
neous, explanations of male overrepresentation in cer-
tain cohorts (in addition to chance) may include X-
linked inheritance in some instances, sex-influenced
expression, and mechanisms related to imprinting
defects [11,12,15,16].
As VACTERL association is likely highly heteroge-
neous, grouping patients through phenotypic and statis-
tical analyses is a critical step in both defining the
overall range of manifestations as well as for the
exploration of potential causes. Such grouping relies
heavily upon careful and thorough clinical examination,
and is important for more than descriptive purposes:
clustering phenotypically similar patients can enhance
consideration of the differential diagnosis and may
reveal a group of patients with features that overlap but
are distinct from VACTERL association [15-17]. Such
analyses can also suggest common, biologically-linked
causes within each cluster, as aberrations affecting
developmentally linked processes may hypothetically
result in similar clinical features [7,15-17]. Determining
t h et y p ea n dr a n g eo ff i n d i n g sm a ya l s op r o v i d ei n s i g h t
into the specific type and temporospatial nature of the
underlying biological perturbation, which can inform
basic and translational studies regarding the pathogenic
mechanism. Additionally, using cluster analysis to
inform studies into causation greatly enhances the
potential for success through newer gene discovery
techniques such as whole-exome sequencing [18].
Finally, clustering of phenotypically similar patients can
allow better prognostic discussions and medical man-
agement decisions (such as highlighting important clini-
cal features that may be more common in patients
within a certain cluster) even when the cause is
unknown.
Several studies have shown evidence for clinically-
defined clusters depending on the type and spatial loca-
tion (eg, “upper vs. lower”) of VACTERL association
component features, as well as the presence of asso-
ciated congenital anomalies [7,15-17]. However, as
d e s c r i b e db e l o w( i nt h es e c t i o no nD i a g n o s i sa n dd i a g -
nostic methods), these clusters may also reflect variable
diagnostic criteria, and accurate assignment of individual
patients to a given cluster may be complicated by issues
such as variable expressivity. Once the causes of the
condition are better delineated, categorization of
patients may be more easily accomplished, and re-ana-
lyzing previously purported clusters will be an interest-
ing endeavor [7,15-17].
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VACTERL association is clinically defined by the pre-
sence of a cluster of congenital malformations. As
described above, most (but not all) clinicians and
researchers require the presence of at least three com-
ponent features, though some place more emphasis on
certain component features [7-9,11-15,19]. Importantly,
there must be no clinical or laboratory-based evidence
of an alternate diagnosis. The following is a discussion
of the specific defining features of VACTERL association
as the condition is most commonly described. However,
it is important to note that the literature demonstrates a
wide degree of interpretation in terms of how diagnostic
criteria are defined and applied, and any patient with
suspected VACTERL association deserves careful
scrutiny.
In several studies, vertebral anomalies, which are com-
monly accompanied by rib anomalies, have been
reported in approximately 60-80% of patients; interest-
ingly, patients may have rib anomalies without vertebral
anomalies [7-9,13,15,20]. Vertebral anomalies typically
include segmentation defects, such as hemivertebrae,
“butterfly vertebrae”, “wedge vertebrae” (the latter two
descriptions refer to the shape of the dysplastic verteb-
rae), and vertebral fusions, supernumerary or absent ver-
tebrae, and other forms of vertebral dysplasia. There is a
wide degree of severity of reported vertebral malforma-
tions. Some patients require multiple, major operations
for vertebral anomalies, while others may have subtle
defects only detectable through careful scrutiny by an
experienced clinician [13,21]. Abnormal spinal curvature
due to underlying costovertebral anomalies is common.
Clinical signs of scoliosis may be the first sign of verteb-
ral anomalies if imaging studies are not performed when
VACTERL association is first suspected [22]. Of note,
while patients with ARM may have dysplastic sacral ver-
tebrae, whether or not these should be included as true
vertebral malformations for the diagnosis of VACTERL
association is unclear [13,21,23]. In fact, while these lat-
ter patients are sometimes described as having VAC-
TERL association (especially if a minor renal anomaly is
present), such a diagnosis is controversial.
Imperforate anus/anal atresia as part of an ARM
occurs in approximately 55-90% of patients [7-9,13,15].
A complete imperforate anus is often discovered in the
immediate postnatal period, typically through routine
examination or due to inability to measure the infant’s
temperature rectally. However, other forms with stenosis
may appear anatomically normal on initial examination,
and may clinically present later with signs of obstruction
[23]. (While beyond the scope of this paper, formal clas-
sification schemes of many of the malformations seen in
VACTERL association, such as ARM and TEF are avail-
able; please see specific references for more details.) As
with other malformations, some controversy exists in
terms of diagnostic criteria. For example, some clini-
cians only allow a completely imperforate anus to be
considered part of VACTERL association (though this
author would argue that this is too narrow a view, and
t h a ts o m ea l l o w a n c es h o u l db em a d ef o ras p e c t r u mo f
severity).
In patients with imperforate anus, genitourinary (GU)
anomalies are also common as part of the ARM, but
GU anomalies may also occur in patients without
imperforate anus or anal atresia. Overall, GU anomalies
occur in up to 25% of patients with VACTERL associa-
tion, and may be less obvious than imperforate anus,
such as is the case with fistulae connecting the GU and
anorectal tracts [23,24].
Cardiac malformations have been reported in approxi-
mately 40-80% of patients with VACTERL association
[9,13,15]. One explanation for the highly variable rates
of cardiac malformations may have to do with ascertain-
ment bias in certain studies. For example, studies using
malformation registries tend to describe higher rates of
cardiac malformations than studies based on children
seen in genetics clinics, as severe cardiac malformations
result in a high rate of mortality. It is important to
point out that some statistically-based analyses argue
that cardiac malformations should not be included in
the diagnostic criteria, as they are not more common in
patients with VACTERL association than in other disor-
ders with multiple malformations [7-9]. Nevertheless,
structural heart anomalies are common in VACTERL
association, and may range from severe structural
defects incompatible with life or necessitating several
stages of challenging surgery, to subtle anatomic defects
ascertained in adulthood only through participation in
research studies, and which would not be expected to
cause any medical issues [13,15,22]. The category of car-
diac defects raises another important point that might
be applied to VACTERL association more generally: cer-
tain variants in isolation (such as patent ductus arterio-
sus or patent foramen ovale) should standardly be
considered a normal, age-based finding rather than a
component feature of VACTERL association, and
researchers and clinicians must be careful not to apply
diagnostic criteria carelessly.
A number of subtypes of tracheo-esophageal fistula
(TEF) may occur, and may present with or without eso-
phageal atresia. Overall, TEF occurs in approximately
50-80% of patients [7-9,13,15]. Early signs of TEF
include polyhydramnios or absent gastric bubble recog-
nized prenatally, inability to pass nasogastric tubes
immediately postnatally, or choking/swallowing in
infancy [25]. TEF typically require surgery in the first
few days of life, and later complications may occur as
well, such as fistula recurrence, reactive-airway disease,
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other pulmonary anomalies may co-occur; these may
share a common structural anatomical cause with the
TEF and/or cardiac anomalies [16,26-29].
Like other malformations seen in VACTERL associa-
tion, there can be a wide range of severity and type of
renal anomalies, which can include unilateral renal
agenesis (or bilateral in severe cases), horsehoe kidney,
and cystic and/or dysplastic kidneys, sometimes accom-
panied by ureteral and GU anomalies [15,24]. Renal
anomalies are reported in approximately 50-80% of
patients [8,9,13,15]. As with cardiac malformations,
some statistical analyses have suggested that renal
anomalies should not be considered one of the defining
component features, as they may only be associated
with certain features such as ARM [7-9]. Unlike many
other features of VACTERL association, which are rela-
tively clinically obvious, renal anomalies may be less
apparent unless careful imaging is performed. Diagnos-
ing occult renal anomalies is especially important, as
these malformations may result in significant morbidity
[30].
Finally, limb malformations have been reported in
approximately 40-50% of patients [7-9,15,17]. While
classically defined as radial anomalies, including thumb
aplasia/hypoplasia, many other limb anomalies have
been ascribed (perhaps erroneously) to VACTERL asso-
ciation, including polydactyly and lower limb anomalies.
As with the other malformations, there is a wide range
of the degree of severity of limb anomalies in affected
patients. One must take care to consider whether the
particular limb anomaly in question should be consid-
ered part of VACTERL association or be taken to be a
sign of a similar disorder in the differential diagnosis.
W h i l et h ea b o v em a l f o r m a t i o n sa r ec o n s i d e r e dt ob e
the core component features, many other malformations
have been described in affected patients [8,9,15,31]. On
review, some of these features are likely signs of other,
similar disorders, such as the finding of craniosynostosis
in patients with Baller-Gerold syndrome, or coloboma
in patients with CHARGE syndrome [13,15,19,32,33].
Clinicians should thus use these non-typical malforma-
tions as a clue in considering possible other conditions,
and should be cautioned to look carefully at other organ
systems that could aid in the differential diagnosis, such
as by obtaining ophthalmologic and audiologic examina-
tions (see Table 1).
Special note should be made of the presence of a sin-
gle umbilical artery, which is frequent in patients with
VACTERL association (though the exact prevalence is
difficult to estimate) [31,34]. This is an especially impor-
tant antenatal finding, as it may be the first sign of the
diagnosis (see the section on Antenatal diagnosis below).
Aetiology
In at least a subset of patients, there is evidence for
familial clustering suggestive of inherited factors [35-37].
However, there is also strong clinical and genetic evi-
dence for causal heterogeneity in patients with VAC-
TERL association [12,15-17]. The vast majority of
genetic causes described in humans have been reported
in isolated individuals or families and overall account
for only a small percentage of patients with VACTERL
association. These causes are outlined in Table 2.
In addition to the small handful of proposed human
etiologies, a number of clues from animal models sug-
gest at least some broad categories of genetic etiologies
for VACTERL association in humans. First, as animals
with mutations in Sonic hedgehog pathway genes (such
as Shh and the Gli genes) have features of VACTERL
association, this pathway has long been implicated
[38,39]. Teratogen-based animal models further support
this hypothesis [40,41]. As humans with loss-of-function
mutations affecting the SHH p a t h w a yh a v eh o l o p r o s e n -
cephaly, it is unsurprising that patients with isolated
VACTERL association do not have SHH mutations
[42-44]. However, it is certainly possible that perturba-
tions of SHH signaling due to interacting pathways may
result in VACTERL association without brain anomalies.
For example, mutations/deletions affecting FOXF1
(which is linked to SHH signaling) results in a VAC-
TERL-like phenotype (though one small study did not
show similar mutations in patients with classic VAC-
TERL association), and a patient has been described
with features of VACTERL association due to a muta-
tion in HOXD13, a downstream target of SHH [45-47].
As VACTERL association appears to be casually het-
erogeneous, it is unsurprising that several key signaling
pathways have also been implicated through animal
models. In addition to classic Sonic hedgehog signaling,
these include disruption of pathways involving Hox and
retinoic acid signaling [48-51]. As many of these path-
ways interact in complex and still incompletely under-
stood ways, it may be better to think of these pathways
as vast intersecting networks involved in developmental
signaling, rather than discrete, linear pathways. In other
w o r d s ,am u t a t i o ni nag e n ek n o w nt ob eak e yp a r to f
one signaling pathway may in fact have multiple effects
across a broad network involving many pathways. The
fact that patients with Fanconi anemia may be observed
to have findings of VACTERL association may provide
another clue to more general etiologies, as Fanconi ane-
mia results in congenital malformations, as well as other
medical issues such as hematologic disturbances and
malignancy, secondary to the accumulation of DNA
damage related to chromosomal instability. In Fanconi
anemia, the exact nature of the anomalies in a particular
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Condition Features in common with
VACTERL association
Features distinct from VACTERL
association
Cause(s) Reference(s)
Alagille syndrome Vertebral anomalies, cardiac
anomalies; may have renal
anomalies
Bile duct paucity and cholestasis,
ophthalmologic anomalies
(especially posterior embryotoxon),
neurological anomalies,
characteristic facial appearance
Heterozygous mutations
in JAG1, NOTCH2
[92-95]
Baller-Gerold syndrome Radial anomalies, may also
include anal anomalies
Craniosynostosis, skin anomalies Heterozygous mutations
in RECQL4
[33]
CHARGE syndrome Cardiac malformations,
genitourinary anomalies; may
also include TEF
Colobomata, choanal atresia,
neurocognitive and growth
impairment, ear anomalies, cranial
nerve dysfunction, characteristic
facial features
Heterozygous mutations
in CHD7
[32,96]
Currarino syndrome Sacral malformations, ARM Presacral mass Heterozygous mutations/
deletions of HLXB9
[97,98]
22q11.2 deletion syndrome (also
known by other names, such as
DiGeorge syndrome or velocardio-
facial syndrome)
Cardiac malformations, renal
anomalies, other VACTERL-type
anomalies also reported
Hypocalcemia, palatal anomalies,
learning difficulties, immune
dysfunction, neuropsychiatric
disturbances, characteristic facial
features,
Deletion of one copy of
chromosome 22q11.2
[99]
Fanconia anemia Virtually all features of VACTERL
association may occur; radial
anomalies are considered an
especially key feature
Hematologic anomalies,
pigmentation anomalies
Recessive or X-linked
mutations in multiple
genes; typically detected
by chromosomal
breakage studies
[62,63,66,100]
Feingold syndrome GI atresia, cardiac defects, renal
anomalies
Brachymesophalangy, toe
syndactyly, microcephaly, cognitive
impairment, characteristic facial
appearance,
Heterozygous mutations
in MYCN
[67,101]
Fryns syndrome GI malformations, cardiac
defects, GU anomalies
Diaphragmatic defects,
neurocognitive impairment,
characteristic facial appearance,
No well-characterized
unifying causes
[102]
Holt-Oram syndrome Cardiac malformations, limb
malformations
Cardiac conduction disease (also
reported in VACTERL association)
Heterozygous mutations
in TBX5
[68,103]
Müllerian duct aplasia, renal aplasia,
and cervico-thoracic somite
dysplasia (MURCS assoc-iation); also
known as Mayer-Rokitansky- Küster-
Hauser syndrome type II
Vertebral anomalies, renal
anomalies, GU anomalies and
anorectal malformations; may
also have cardiac and limb
anomalies
Syndactyly and hearing loss have
been described
Unknown; likely
heterogeneous
[104,105]
Oculo-auriculo-vertebral syndrome Vertebral anomalies, cardiac
abnormalities, limb
abnormalities, urogenital
anomalies
Ear anomalies (microtia), hemifacial
microsomia, neurocognitive
impairment, facial clefts (also
described in patients with
VACTERL association)
Unknown; likely
heterogeneous
[106]
Opitz G/BBB syndrome Anal anomalies, heart defects,
TEF, hypospadias
Hypertelorism, syndactyly X-linked form:
heterozygous/
hemizygous mutations in
MID1; autosomal
dominant form: some
cases due to deletion
22q11.2
[107-109]
Pallister-Hall syndrome Imperforate anus, renal
anomalies, limb anomalies
(postaxial polydactyly should
serve as a clue for the Pallister-
Hall syndrome)
Hypothalamic hamartoma, bifid
epiglottis (ranging to more severe
types of clefts), nail hypoplasia
Heterozygous mutations
in GLI3
[110-112]
Townes-Brocks syndrome Imperforate anus, thumb
anomalies, renal anomalies,
cardiac anomalies
Dysplastic ears, hearing loss Heterozygous mutations
in SALL1
[69,113]
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mations, is thought to relate to stochastic events [52].
As well as classical genetic causes, a number of envir-
onmental influences have been implicated, but there is
little firm data that would be helpful in counseling
patients beyond what is known about teratogens more
generally. Reported influences include maternal diabetes,
which may result in features of VACTERL association
due to multiple factors (these may ultimately be shown
to be related to a common pathway). These factors
include direct effects of hyperglycemia, oxidative stress
and reactive oxygen species, interactions with certain
key developmental pathways in genetically vulnerable
patients, and, intriguingly, because of patients with
genetically-related mitochondrial dysfunction and VAC-
TERL association, mitochondrial damage [53-56]. In
addition to maternal diabetes, other reported environ-
mental factors include infertility treatment, and in utero
exposure to estrogen and/or progesterone-containing
compounds, statins, lead, and, for at least ARM, a num-
ber of additional maternal and paternal risk factors and
exposures [6,10,11,37,57-59]. Again, these reports must
be regarded with caution, as the association between the
exposure and the presence of VACTERL association
may be speculative. While there is stronger evidence for
the association between maternal diabetes and birth
defects, the increased relative risk here, as elsewhere,
points to a multifactorial etiology in which environmen-
tal triggers interact with a genetic susceptibility [60,61].
Diagnosis and diagnostic methods
Diagnosis of VACTERL association is made on clinical
grounds, based on the presence of the congenital mal-
formations outlined above (in the Clinical description
section). As described in the section on Definition and
diagnostic criteria, the requirements for diagnosis vary
among clinicians and researchers. Many (but not all)
require at least three component features for diagnosis,
without clinical or laboratory-based evidence of the
many overlapping conditions, while others emphasize
the presence of certain component features, especially
TEF or ARM. Another diagnostic approach involves
requiring the presence of spatially disparate anomalies
(such as occurring both above and below the diaphragm
in the same patient) (see Table 1 regarding differential
diagnosis) [7-15,19].
As the condition is clinically based, testing techniques
recommended for patients suspected to have VACTERL
association are outlined in Table 3[22].
Differential diagnosis
The differential diagnosis of VACTERL association is
broad, and includes a number of conditions for which
genetic testing is available (Table 1). Often, subtle clues
on a careful physical examination and family history can
help narrow down which conditions are most likely in a
patient with features of VACTERL association. For
example, autosomal dominant inheritance of certain fea-
tures may suggest Townes-Brocks syndrome, and the
Table 1 Differential diagnosis: conditions with multiple features in common with VACTERL association (Continued)
VACTERL-H All core component features Hydrocephalus Heterozygous mutations
in PTEN, heterozygous/
hemizygous mutations in
ZIC3; X-linked and
recessive forms have
been described
[64,65,90,114]
There are also many scattered case reports in the medical literature describing additional patients who have features observed in VACTERL association, but only
the main overlapping conditions are described here.
GI: gastrointestinal; GU: genitourinary; H:hydrocephalus; TEF: tracheo-esophageal fistula
Table 2 Reported causes of features seen in VACTERL association in human patients
Cause Notes Reference
(s)
Mitochondrial dysfunction Patients typically have clinical features consistent with mitochondrial dysfunction (though these may not be
apparent until long after the malformations associated with VACTERL association have been discovered)
[77-81]
Pathogenic copy number
variations
Many different deletions/duplications have been reported*, though the evidence for causation of VACTERL
association-type features is not uniformly clear. Clinical features in patients with large genomic imbalances
often include malformations and medical issues not commonly seen in VACTERL association (such as
neurocognitive impairment)
[82-86]
Heterozygous mutations
in HOXD13
Described in one patient; mutations in HOXD13 are more typically reported as resulting in limb and/or
urogenital anomalies
[51,87,88]
Heterozygous/
hemizygous mutations in
ZIC3
Clinical features may or may not include obvious heterotaxy/situs abnormalitites [89-91]
*A number of references have been listed here, but this is not an exhaustive list.
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TERL association may suggest other disorders, such as
pigmentary abnormalities in Fanconi anemia, or hypo-
calcemia in deletion 22q11.2 syndrome. Naturally, this
examination is best conducted by individuals who are
familiar with VACTERL association and similar
disorders.
Ruling-out these conditions is a challenging but criti-
cal part of the diagnostic work-up, and is essential for
proper genetic counseling, as there is genetic testing
available for a number of these overlapping disorders.
Ruling-out these disorders will include testing to look
carefully for certain features that are not typical of
VACTERL association, such as brain malformations,
ophthalmologic anomalies, and hearing deficits. As men-
tioned, some of these similar disorders occur in an
inherited manner, though with incomplete penetrance
and highly variable expressivity.
Although a controversial issue, it is worthwhile to
make special note of Fanconi anemia in the differential
diagnosis. There is efficient and relatively affordable
testing available for this condition, and it would be
important to rule out Fanconi anemia, both for reasons
of genetic counseling (as inheritance may be autosomal
recessive or X-linked), and also because of the associa-
tion of hematologic anomalies and malignancies with
Fanconi anemia. Proper surveillance for these complica-
tions in patients with identified Fanconi anemia could
potentially improve outcomes [62,63].
Genetic counseling
Given the lack of informative data available, genetic
counseling for patients and families affected by VAC-
TERL association can be difficult. Approximately 90% of
cases of VACTERL association appear to be sporadic,
with little increased risk of having multiple affected indi-
viduals within a family [36]. However, single or multiple
malformations associated with VACTERL association
are observed in up to 10% of first-degree relatives of
patients with VACTERL association; in other words,
there is evidence for an inherited component in a subset
of patients [35-37]. Therefore, a careful family history,
with further clinical investigation as necessary is a key
part of any genetic evaluation for patients with VAC-
TERL association. In families in which multiple mem-
bers are affected, it is important to note that it is
uncommon for all affected individuals to meet full cri-
teria of for VACTERL association. A more common sce-
nario is a proband with VACTERL association who has
relatives who may have single component features of
VACTERL association, such as isolated (and generally
milder) vertebral, cardiac, or renal malformations. The
presence of these families points to a complex inheri-
tance pattern involving multiple interacting genetic and
environmental factors. Causality in these situations can
be difficult to ascertain, which makes accurate genetic
counseling challenging. As our understanding of the
causes of many congenital malformations continues to
grow, patients and families might be counseled to con-
tinue to inquire about newly discovered causes and test-
ing modalities that could shed light on their particular
situation.
Along these lines, a common and central question that
arises during genetic counseling has to do with recur-
rence risk in affected families. While an exact number is
difficult to pinpoint generally, the recurrence risk is
likely relatively low as long as similar conditions with
inherited forms are ruled-out (such as Fanconi anemia,
Feingold syndrome, Holt-Oram syndrome, Townes-
Brocks syndrome, and VACTERL with hydrocephalus)
Table 3 Diagnostic methods
Feature Intitial test(s) Notes
Vertebral
anomalies
X-ray; ultrasound and/or MRI of the spine X-ray may not show subtle spinal anomalies, and will be unable to detect
associated anomalies such as tethered cord or syrinx
Anal atresia Physical examination/observation, abdominal
ultrasound for genitourinary anomalies
Additional testing is typically required to define anatomy, especially if
concomitant genitourinary anomalies are present
Cardiac
malformations
Echocardiogram Other, more precise techniques, such as cardiac CT or MRI may be helpful to
further detail anomalies
Tracheo-
esophageal
fistula
Physical examination/observation (contrast studies
are rarely required)
Patients with VACTERL association but without true TEF may still present with
swallowing/breathing anomalies, and clinicians should have a low index of
suspicion for confirmatory radiological testing
Renal
anomalies
Renal ultrasound Further testing, such as a voiding cystouerethrogram, may be required in the
presence of renal anomalies or if there is other evidence of issues such as
vesicoureteral reflux
Limb anomalies Physical examination, X-rays Important not to overlook, as the presence of limb anomalies often prompts
testing for Fanconi anemia
Suggested testing for patients (in addition to a careful physical examination by an experienced clinician) suspected to have VACTERL association. Specific
modalities used should be dictated by the risk-benefit ratio for the specific situation.
CT: computed tomography; MRI: magnetic resonance imaging; TEF: tracheo-esophageal fistula
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family may be made based on family history, as specific
families may appear to segregate VACTERL association
type malformations according to a certain inheritance
pattern [36].
As with other relatively rare conditions, patient and
family-based resources and support groups can be
invaluable. For VACTERL association, a number of
these groups exist, including: The Pull-Thru Network
(United States-based; primarily for patients whose medi-
cal issues include ARM: http://www.pullthrunetwork.
org); The VACTERL Network (United States-based:
http://www.vacterlnetwork.org); TOFS (United-Kingdom
based; primarily for patients whose medical issues
include tracheo-oesophageal fistula: http://www.tofs.org.
uk); VACTERL Association Support Group (United
Kingdom-based: http://www.vacterl-association.org.uk).
Antenatal diagnosis
As with many other conditions, the ability to detect fea-
tures of VACTERL association prenatally, whether
through ultrasound or more sophisticated methods such
as prenatal echocardiogram or MRI, is very much
dependent on the skill and experience of the medical
interpreter. Certain features of VACTERL association,
such as ARM or TEF are often not detected prior to
delivery, even with frequent and careful prenatal ima-
ging; naturally, this can be distressing to affected
families, especially as such malformations can be asso-
ciated with significant morbidity and mortality.
However, certain clues can suggest VACTERL-type
anomalies, such as polyhydramnios and lack of a gastric
bubble due to TEF, and a dilated colon due to imperfo-
rate anus [34,70]. Other features, such as some types of
vertebral anomalies, cardiac malformations, renal
anomalies, and limb abnormalities, may be ascertained
more easily by antenatal ultrasound [71,72].
It is important to emphasize that the discovery of a
single umbilical artery (SUA) may be the first clue to
diagnosis. The presence of SUA should always result in
a careful antenatal examination for features of VAC-
TERL association as well as for other congenital anoma-
lies [34,73].
Management
The management of patients with VACTERL association
can be complex, and the nuances of treating issues
related to each component feature are not covered in
this manuscript; the reader interested in a more in-
depth discussion might examine some of the referenced
articles covering these topics in greater detail. Overall,
the management of affected individuals might be
thought of as divided into two stages. First of all, condi-
tions that would be incompatible with life, such as
severe cardiac malformations, imperforate anus, and
TEF, are typically managed with surgery in the immedi-
ate neonatal period or as soon as circumstances allow.
For example, imperforate anus may be treated with an
immediate colostomy, followed later by re-anastamosis
and “pull-through” surgery; accompanying genitourinary
anomalies are also frequently treated in a staged manner
[74]. The correction of cardiac malformations may also
require multiple surgeries, depending on the specific
type of congenital defect. TEF are typically repaired in a
single surgery, though later complications (such as fis-
tula re-occurrence) may necessitate more procedures
[25].
Second, many of the congenital malformations can
result in longer-term sequelae, as outlined in Table 4.
One of the most important themes in managing patients
with VACTERL association is recognizing that some
congenital malformations may be subtle yet medically
important, such as vertebral anomalies that can result in
severe back pain later in life [22], or renal anomalies
that can predispose to infections, nephrolithiasis, and
declining renal function. Managing clinicians must keep
these long-term issues in mind [30]. Typically, the role
of the clinical geneticist may not involve system-specific
outcomes or sequelae after the initial diagnostic period,
though some geneticists may find a role in coordination
of care.
Prognosis
With improvements in surgical techniques and in spe-
cialized neonatal and post-surgical facilities, the diagno-
sis of VACTERL association yields a much better
prognosis than previously [19,22,74-76]. Nonetheless,
even with optimal surgical corrections of malformations
such as cardiac anomalies, TEF, and limb abnormalities,
patients can face considerable medical challenges
throughout life [22,74,76]. Component-specific sequelae
are described in Table 4.
Special consideration should be made for ARM. In
terms of functional outcome, there is wide variability.
However, referral to a highly experienced center with a
coordinated, multidisciplinary team, can greatly improve
outcomes even among those who have been initially
been given relatively grim prognoses regarding issues
such as continence. Patients and families, as well as
treating clinicians, should be encouraged to seek care
through such specialty clinics in order to attempt to
achieve the best possible outcome [76].
Finally, despite significant morbidity associated with
the component congenital malformations, it is also
important to note that patients with VACTERL associa-
tion do not typically display neurocognitive impairment
(in fact, the presence of neurocognitive impairment
should strongly suggest an alternate diagnosis) [19,22].
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While much remains unresolved, a central and critical
question regarding VACTERL association hinges on the
causes. Unlike many other conditions whose genetic
causes were discovered over the last several decades, the
etiologies of VACTERL association remain largely
unknown. There are many reasons for this, including
likely clinical and causal heterogeneity, the typical spora-
dic nature of the disease, and the many overlapping
conditions. Coupling insights from biological models
with newly available genomic technologies may begin to
offer more answers about causation in the near future.
These answers may then, with more dedicated research,
be turned to an even more crucial question: how to
improve the health of affected patients and families.
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